Physician profile
Young S Chae
NPI 1124136031
$2,277.83
in general payments reported to CMS, 2019-2025
14 companies · $573 in 2025
The $573 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $207 · 2021: $196 · 2022: $261 · 2023: $368 · 2024: $376 · 2025: $573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,317.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $975.32 | 2020-2025 | Rinvoq, Skyrizi, Mavyret |
| Gilead Sciences, INC. | $462.40 | 2019-2022 | |
| Redhill Biopharma INC. | $151.21 | 2020-2024 | Talicia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $139.26 | 2019-2024 | Trulance |
| Pharmacosmos Therapeutics INC. | $125.00 | 2025 | Monoferric |
| Takeda Pharmaceuticals U.S.A., INC. | $95.96 | 2021-2025 | Entyvio |
| Vivus LLC | $91.96 | 2022-2025 | Qsymia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.27 | 2025 | |
| Jazz Pharmaceuticals INC. | $45.19 | 2023 | |
| Qol Medical, LLC | $41.92 | 2021 | |
| Intercept Pharmaceuticals, INC. | $30.65 | 2020-2021 | |
| Shionogi INC | $22.68 | 2019 | |
| Lilly USA, LLC | $22.01 | 2024 | Omvoh |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Young Chae listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.